tiprankstipranks
Replimune Group (REPL)
NASDAQ:REPL
US Market
REPL
Replimune Group
RESEARCH TOOLSreports
Want to see REPL full AI Analyst Report?

Replimune Group (REPL) Stock News & Sentiment

504 Followers
REPL Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
REPL Earnings this Week: How Will it Perform?
5d ago
REPL
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/13/2026?
Premium
Market News
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/13/2026?
1M ago
IMA
VTI
Replimune: Binary RP1 PDUFA Outcome and Funding Overhang Justify Hold Rating
Premium
Ratings
Replimune: Binary RP1 PDUFA Outcome and Funding Overhang Justify Hold Rating
2M ago
REPL
Replimune amends Hercules loan, strengthens funding runway
Premium
Company Announcements
Replimune amends Hercules loan, strengthens funding runway
3M ago
8K
REPL
Replimune Highlights RP1, RP2 Progress Ahead of JPM Conference
Premium
Company Announcements
Replimune Highlights RP1, RP2 Progress Ahead of JPM Conference
4M ago
8K
REPL
Replimune Group Reports Increased Losses Amid R&D Expansion
Premium
Company Announcements
Replimune Group Reports Increased Losses Amid R&D Expansion
6M ago
REPL
Positive Outlook for Replimune Group: Buy Rating Affirmed on Promising RP1 + Opdivo Therapy and Strong Financial Position
Premium
Ratings
Positive Outlook for Replimune Group: Buy Rating Affirmed on Promising RP1 + Opdivo Therapy and Strong Financial Position
6M ago
REPL
More REPL News >

REPL News on the Web

Legal Investigation Spotlights Replimune (REPL) After FDA Setback—What Are the Next Steps for Investors?
Market Chameleon
Bearish
FDA Commissioner Marty Makary resigns
TipRanks News
Neutral
Trump confirms Kyle Diamantas to be acting head of FDA
TipRanks News
Neutral
Replimune (REPL) Stock Rises Amid FDA Commissioner Marty Makary's Departure
GuruFocus News
Bullish
Trump says Makary is out as FDA commissioner, following industry and White House backlash
CNBC
Bearish
REPL Earnings this Week: How Will it Perform?
TipRanks News
Bearish
Replimune jumps on news FDA chief behind RP1 rejection may be removed
TipRanks News
Bullish
FDA commissioner defends agency's drug approval decisions after wave of backlash
CNBC
Bearish

News Score - Last 7 Days

Negative
REPL
Sector Average
Media Buzz
This Week6 articles
Weekly Average5 articles
News Sentiment
This Week25%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is REPL’s Media Buzz Sentiment?
6 articles about REPL were published this week. In an average week, 5 articles are published.
    What is REPL’s weekly average amount of articles?
    In an average week, 5 articles about REPL are published.
      What is REPL’s News Sentiment?
      25% of articles about REPL were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week